|
TRANSIENT ELEVATIONS IN SERUM CREATININE
|
DIDANOSINE SHOULD BE TAKEN 2 HRS AFTER OR 6 HRS BEFORE QUINOLONES LIKE CIPROFLOXACIN
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
QUINOLONES MAY INCREASE THE EFFECT OF THEOPHYLLINE
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
CO-ADMINISTRATION OF QUINOLONES WITH ANTACIDS CONTAINING MAGNESIUM, CALCIUM, OR ALUMINUM MAY SUBSTANTIALLY INTERFERE WITH THE ABSORPTION OF QUINOLONES, IT SHOULD BE BE TAKEN 4 HOURS BEFORE OR 8 HRS. AFTER INGESTION OF ANTACIDS
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
QUINOLONES MAY INCREASE THE PLASMA LEVELS OF THE DRUG
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; ANTACIDS SHOULD BE GIVEN 2 HRS. AFTER OR 6 HRS. BEFORE COPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CO-ADMINISTRATION WITH SUCRALFATE MAY SUBSTANTIALLY INTERTERE WITH THE ORAL ABSORPTION OF QUINOLONES ; IT SHOULD BE TAKEN 6 HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION OF OTHER DRUGS KNOWN TO ALTER CARDIAC CONDUCTION, SUCH AS ERYTHROMYCIN, MIGHT ALSO CONTRIBUTE TO A PROLONGATION OF THE QTC INTERVAL & INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION OF OTHER DRUGS KNOWN TO ALTER CARDIAC CONDUCTION, SUCH AS ERYTHROMYCIN, MIGHT ALSO CONTRIBUTE TO A PROLONGATION OF THE QTC INTERVAL & INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION OF OTHER DRUGS KNOWN TO ALTER CARDIAC CONDUCTION, SUCH AS ERYTHROMYCIN, MIGHT ALSO CONTRIBUTE TO A PROLONGATION OF THE QTC INTERVAL & INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION OF OTHER DRUGS KNOWN TO ALTER CARDIAC CONDUCTION, SUCH AS ERYTHROMYCIN, MIGHT ALSO CONTRIBUTE TO A PROLONGATION OF THE QTC INTERVAL & INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION OF OTHER DRUGS KNOWN TO ALTER CARDIAC CONDUCTION, SUCH AS ERYTHROMYCIN, MIGHT ALSO CONTRIBUTE TO A PROLONGATION OF THE QTC INTERVAL & INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
CO-ADMINISTRATION WITH AN ALUMINIUM AND MAGNESIUM CONTAINING ANTACID RESULTED IN A REDUCTION IN PLASMA CELECOXIB CONCENTRATION WITH A DECREASE OF 37% IN CMAX AND 10% IN AUC
|
CO-ADMINISTRATION WITH AN ALUMINIUM AND MAGNESIUM CONTAINING ANTACID RESULTED IN A REDUCTION IN PLASMA CELECOXIB CONCENTRATION WITH A DECREASE OF 37% IN CMAX AND 10% IN AUC
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; IT MAY BE ADMINISTERED 2 HRS AFTER OR 6 HOURS BEFORE CIPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
CONCURRENT ADMINISTRATION OF THESE ANTACIDS MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF CIPROFLOXACIN ; IT MAY BE ADMINISTERED 2 HRS AFTER OR 6 HOURS BEFORE CIPROFLOXACIN DOSING WITHOUT A SIGNIFICANT DECREASE IN BIOAVAILABILITY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
POTENTIAL FOR SEVERE AND FATAL REACTIONS INCLUDING CARDIAC ARREST, SEIZURES, RESPIRATORY FAILURE AND STATUS EPILEPTICUS ; CONCURRENT USE SHOULD BE AVOIDED OR SERUM LEVELS OF THEOPHYLLINE SHOULD BE MONITORED CAREFULLY
|
REDUCED CLEARANCE OF CAFFEINE AND A PROLONGATION OF ITS SERUM HALF-LIFE
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CNS EXCITATION MAY OCCUR WITH CONCURRENT ADMINISTRATION; MAY CAUSE CONVULSIONS
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
CO-ADMINISTRATION WITH CALCIUM-CONTAINING, MAY SUBSTANTIALLY INTERFERE WITH THE ORAL ABSORPTION OF QUINOLONES ; THESE PREPARATIONS MAY BE TAKEN SIX HRS. BEFORE OR 2 HRS. AFTER TAKING CIPROFLOXACIN
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|
ADDITIVE ACTIVITY OFTEN RESULTS WHEN QUINOLONES ARE COMBINED WITH AMINOGLYCOSIDES
|